Article

The effect of ovariectomy and long-term estrogen replacement on bladder structure and function in the rat.

Division of Urologic Research, Albert Einstein College of Medicine, The Bronx, New York, USA.
The Journal of Urology (Impact Factor: 3.75). 09/2002; 168(3):1265-8. DOI: 10.1097/01.ju.0000023406.93873.08
Source: PubMed

ABSTRACT PURPOSE The use of estrogen replacement therapy for treating postmenopausal urinary incontinence is a controversial topic. We examined the behavioral, cystometric and histological changes that occur with long-term estrogen depletion and supplementation in rat bladders to determine the role of menopause in lower urinary tract dysfunction. MATERIALS AND METHODS A total of 40 female Sprague-Dawley rats were placed into 1 of 3 groups, including bilateral ovariectomy, bilateral ovariectomy plus estrogen replacement and control. The estrogen replaced group received a 0.25 mg. 16-week sustained release pellet (Innovative Research of America, Sanasota, Florida) placed subcutaneously. After surgery voiding frequency and volume were measured in 24-hour periods by placing animals in metabolic cages. After 16 weeks the rats underwent catheterization and continuous cystometry. The bladder was then removed and stained with Gomori trichrome. The collagen-to-smooth muscle density ratio was calculated for each specimen using current imaging software. RESULTS There was no significant difference in voiding patterns in the 3 groups, as measured by volume and voiding frequency. Cystometric data showed a trend toward higher voiding pressure, threshold pressure, baseline pressure and mean inter-voiding pressure in the ovariectomy group compared with the estrogen and control groups, although there was no statistical significance. Histological studies showed a higher mean collagen-to-smooth muscle ratio plus or minus standard deviation in the ovariectomy group (0.807 +/- 0.204) than in the ovariectomy plus estrogen replacement (0.709 +/- 0.118) and control (0.700 +/- 0.129) groups (p <0.05). Furthermore, when histological and cystometric data were compared for individual samples, we found a direct correlation of mean inter-voiding pressure (a measure of bladder instability) with the collagen-to-smooth muscle ratio (p <0.05). CONCLUSIONS Long-term estrogen replacement is beneficial for treating postmenopausal urinary incontinence.

0 Bookmarks
 · 
101 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Urinary incontinence (UI), defined as the involuntary loss of urine during the filling phase of the bladder (Abrams et al. 2002), is a commonly seen problem in veterinary practice. Urinary sphincter mechanism incompetence (USMI) after spaying is the most common micturition disorder, and its medical treatment is normally successful, even though the underlying pathophysiological mechanism is not fully understood. Hormonal changes inducing structural and functional alterations in the bladder, as well as in the urethra composition, are discussed. To manage incontinent patients successfully, possible underlying abnormalities besides USMI should be ruled out. In the majority of cases, history, physical examination and simple tests including urinalysis and urine bacterial culture lead to a presumed aetiology. If USMI is the most likely cause, then the advantage of further diagnostic tests should be discussed with the owner before starting a trial therapy with alpha-adrenergic drugs. Potential side effects of this therapy have to be mentioned even though they rarely occur. It is important to thoroughly evaluate the success of the initial treatment. Its failure should lead to further diagnostic testing. Specialized clinical assessments may provide an aetiological diagnosis, and this could serve as a basis for discussing further treatment options. Surgical procedures, which may in rare cases cause irreversible side effects, may be instituted. If incontinence reoccurs after initial treatment was successfully performed, the diagnostic work-up including urinalysis should always be repeated. As results of urinalysis did not correlate well with results of bacterial culture, a urine culture is recommended (Comer and Ling 1981). Cystocentesis is the preferred method of urine collection (Bartges 2004). Equivocal results of quantitative cultures of urine samples obtained during midstream voiding or by catheterization require repeat collection by cystocentesis (Comer and Ling 1981).
    Reproduction in Domestic Animals 06/2014; 49 Suppl 2:75-80. DOI:10.1111/rda.12298 · 1.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: Testosterone (T) affects male development, maturation, and aging, but limited data exist on testosterone effects on the juvenile genitourinary system. We hypothesized that T has bladder and kidney developmental effects, and investigated this in juvenile male rats. Materials and Methods: To examine T effect, prepubertal male Wistar rats (age 21 days) were divided among 3 groups: sham orchiectomy--control (S, N=12), bilateral orchiectomy and vehicle (OV, N=12), and bilateral orchiectomy and T (OT, N=12). From age 28 days (week 0, W=0) testosterone enanthate (T, 5 mg/100g) or vehicle were injected weekly. T was measured at W=0 (before injection), and weeks 1, 6, and 16 (W=0, 1,6,16). Whole bladders and kidneys were evaluated for androgen receptor (AR), bladder collagen to smooth muscle ratio (C/M), and renal morphometry and immunohistochemistry. Results: T was not detectable (ND) at W=0 for all groups, and remained ND at W=1, 6,16 for OV rats. T levels were physiologic in S and OT rats, but OT had higher levels than S rats. OT rats had increased bladder/body weight (BW, P<0.01), kidney/BW (p<0.05) ratios, and decreased C/M ratio compared with OV and S rats. OT rats had lower renal total glomerular count (p<0.01) but increased AR density. Conclusions: In juvenile male rats T was associated with increased bladder and renal mass and increased bladder smooth muscle. T associated kidneys also appeared to have fewer but larger glomeruli. These data support an important role for sex hormones in structural and functional development within the bladder and kidney.
    The Journal of urology 06/2014; 191(6). DOI:10.1016/j.juro.2014.01.012 · 3.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The postmenopausal hypoestrogen status induces various lower urinary tract (LUT) dysfunctions. Ovariectomized rats exhibit voiding abnormalities, including increased post voiding residual urine (PVR), decreased voiding efficiency (VE) and altered coordination between the detrusor and external urethral sphincter (EUS). Estradiol replacement partially normalizes voiding function in ovariectomized rats. We determined if selective agonists for ERα and/or ERβ can reverse LUT dysfunction in ovariectomized rats. Cystometry and EUS electromyogram (EUS EMG) were recorded 6 weeks after bilateral ovariectomy (OVX) in urethane-anesthetized female Sprague-Dawley rats. Animals received daily subcutaneous injections of selective ERα (propyl pyrazole triol, PPT) or ERβ (diarylpropionitrile, DPN) agonists or vehicle for 1 week starting on the 5(th) week after ovariectomy. PPT (1 mg/kg/day) decreased PVR, improved VE, and shortened EUS EMG active period (AP) during voiding. DPN (2 or 5 mg/kg/day) did not alter cystometric parameters or EUS EMG activity. Combined PPT-DPN treatment elicited changes in PVR, VE, and AP, similar to those induced by PPT alone but also increased the EUS EMG silent period (SP) and VT for triggering micturition. PPT increased uterine weight (UW) 4 fold and decreased body weight (BW) by 11%. DPN increased UW 30-45%, but decreased BW by 3-5%. Reduced voiding efficiency in OVX rats can be reversed by 1 week drug treatment that selectively targets ERα and reduces AP during EUS bursting. Combined pharmacological activation of ERα and ERβ further enhanced EUS bursting by increasing SP and also facilitated bladder storage mechanisms by increasing VT.
    AJP Renal Physiology 11/2013; 306(2). DOI:10.1152/ajprenal.00298.2013 · 4.42 Impact Factor